CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

TCRXTScan Therapeutics, Inc.

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $0.31 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$7.54M
RECENT INSIDER TRADES
  • 2026-10-02 · ZDRAVESKI ZORAN (See Remarks) · OTHER
  • 2026-10-02 · MacBeath Gavin (Chief Executive Officer) · OTHER
  • 2025-12-23 · Lynx1 Capital Management LP (10% Owner) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders66
Shares held43,255,053
Value$62.40M
Percent of shares outstanding180.40%
As of quarter end2026-06-30
RECENT NEWS
  • TScan Therapeutics, Inc. · 8-K (5.02)
  • TScan Therapeutics, Inc. · 8-K (2.05,3.01,5.02,7.01,8.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS